Zephyrm breezes towards Hong Kong IPO

Today’s Big News

Oct 2, 2024

Triveni ropes in $115M series B less than a year after $92M fundraise

Big pharma, biotech relations ‘won't necessarily be symbiotic’ in future AI landscape: S&P

Zephyrm rides IPO updraft toward Hong Kong listing, seeking cash for phase 3 cell therapy trials

Frazier Life Sciences adds $630M to 'evergreen' fund for small and mid-cap biotechs

Nasal spray neutralizes army of respiratory diseases and protects mice from deadly influenza

Lundbeck taps Charles River for AI-enabled neuro drug discovery

The Top Line Podcast: Don’t miss out on the newest episode. Listen now.

 

Featured

Triveni ropes in $115M series B less than a year after $92M fundraise

By Gabrielle Masson

Triveni Bio has roped in $115 million to advance preclinical antibody treatments designed to take on immunological and inflammatory disorders.
 

Top Stories

Big pharma, biotech relations ‘won't necessarily be symbiotic’ in future AI landscape: S&P

By Gabrielle Masson

Big Pharma is investing heavily in AI to slash development timelines and foster innovation. But instead of strengthening future relationships with the biotech world, the investment may position independent AI-focused biotechs as a threat to pharma’s internal R&D processes.

Zephyrm rides IPO updraft toward Hong Kong listing, seeking cash for phase 3 cell therapy trials

By Nick Paul Taylor

Zephyrm Bioscience is gusting toward the Hong Kong stock exchange, filing for an IPO to bankroll phase 3 trials of its cell therapy in a lung condition and graft-versus-host disease.

Frazier Life Sciences adds $630M to 'evergreen' fund for small and mid-cap biotechs

By James Waldron

Frazier Life Sciences has sourced a further $630 million for its fund focused on small and mid-cap biotechs.

Nasal spray neutralizes army of respiratory diseases and protects mice from deadly influenza

By Darren Incorvaia

The COVID-19 pandemic made us acutely aware of how vulnerable our noses are. The nose is a gateway to infection for respiratory pathogens like influenza and SARS-CoV-2, but our options to shield our nasal passageways from disease are limited.

Lundbeck taps Charles River for AI-enabled neuro drug discovery

By Nick Paul Taylor

Lundbeck has tapped Charles River Laboratories’ artificial intelligence capabilities to aid the discovery of neuroscience treatments, partnering with the service provider to use Logica in its research projects.

High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project

By Kevin Dunleavy

Eli Lilly is making another massive investment, revealing it will build a $4.5 billion R&D and manufacturing facility dubbed the Lilly Medicine Foundry that will “drive innovation in drug production and make medicines for clinical trials," the company said. It will add to the huge project the company is constructing in Lebanon, Indiana.

Amgen can't sidestep investor lawsuit over $10.7B tax bill

By Fraiser Kansteiner

New York District Judge John Cronan has rejected Amgen’s motion to dismiss an investor lawsuit—originally filed by a Michigan-based union pension fund—accusing the company of hiding a $10.7-billion tax bill from the public.

Verrica narrows Ycanth sales focus, rejigs commercial team and plots layoffs in cost-cutting drive

By Ben Adams

Dermatology biopharma Verrica Pharmaceuticals is lining up a cost-cutting plan that is prompting a major shake-up of its commercial teams and a narrowed focus on how it sells its only approved drug.

FDA clears Pi-Cardia's leaflet-splitting device for valve-in-valve TAVR procedures

By Conor Hale

Pi-Cardia’s ShortCut device received a de novo clearance to open up old heart valve implants and clear the blood flow into the coronary arteries.

Wyden, Brown urge FTC to investigate PBM 'co-manufacturing' arrangements

By Paige Minemyer

Two key senators are urging the Federal Trade Commission to investigate "co-manufacturing" arrangements that they fear pharmacy benefit managers may be using to stymie competition.
 
Fierce podcasts

Don’t miss an episode

ESMO, WCLC lung cancer data spark hope—and debate

In this week's "The Top Line," Fierce journalists discuss key issues from promising but debated lung cancer data at recent conferences.

Former VA Secretary Shulkin on the future of health policy

Recapping Digital Pharma East 2024

 

Resources

Whitepaper

Accelerating Timelines to Clinic with GPEx® Lightning

Unlock the Future of Biotherapeutics with Catalent Biologics!

Sponsored by: Catalent Biologics

Whitepaper

Epilepsy Clinical Trials

Finding an effective epilepsy treatment can be arduous. Download this brochure to delve into how IQVIA's expertise and innovative strategic approach can streamline the clinical trial process, helping to get new therapies to patients who need them sooner.

Sponsored by: IQVIA

Whitepaper

Unique Solutions for Drug Discovery and Development

Unique Solutions for Drug Discovery and Development

Sponsored by: Cell Signaling Technology

Whitepaper

Why Biotech Sponsors Need Outside Support: IRB, IBC, DMCs, and EACs

When the fate of your company hangs in the balance, you need expert guidance to navigate the complexities of biotechnology development and to make informed decisions.

Sponsored by: WCG

Whitepaper

HPV-based cervical cancer screening: Gaining insights in sample preference and cost-effectiveness.

Power non-invasive, self-sampling solutions using the Colli-Pee™️ first-void urine collection device. Learn more.

Sponsored by: DNA Genotek

Whitepaper

Overcoming drug development hurdles with phase-appropriate technology transfers

Facing roadblocks in drug development? Uncover how phase-appropriate technology transfers can help you navigate challenges and speed up your journey to market.

Sponsored by: Veranova

 

Industry Events

On Helix

Date: ‌4 ‌July ‌2024 ‌- ‌Location: ‌Babraham ‌Research ‌Campus, ‌Cambridge ‌UK

 

Upcoming Fierce Events

18-19
Nov
Diversity, Equity & Inclusion Forum
Free Virtual Event
20
Nov
Advanced Therapies: Cell & Gene, mRNA and Beyond
Free Virtual Event
27
Nov
Fierce Life Sciences Innovation Awards
Submissions Deadline Sept 12th
27
Nov
Fierce Healthcare Innovation Awards
Submissions Deadline Sept 12th
4
Dec
Cybersecurity: Risks, Strategies and Policies for 2025​
Free Virtual Event

View all events